Personalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Personalis (Nasdaq: PSNL), a leading company in advanced genomics for precision oncology, has announced its management team's upcoming participation in the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference. The event is scheduled to take place on Tuesday, February 11, 2025, at The Cliff Lodge in Snowbird, Utah.
Personalis (Nasdaq: PSNL), un'azienda leader nella genomica avanzata per l'oncologia di precisione, ha annunciato la prossima partecipazione del suo team dirigenziale alla Conferenza Annuale MedTech, Salute Digitale, Scienze della Vita e Strumenti Diagnostici di BTIG. L'evento si svolgerà martedì 11 febbraio 2025, presso il The Cliff Lodge a Snowbird, Utah.
Personalis (Nasdaq: PSNL), una empresa líder en genómica avanzada para la oncología de precisión, ha anunciado la próxima participación de su equipo directivo en la Conferencia Anual de MedTech, Salud Digital, Ciencias de la Vida y Herramientas Diagnósticas de BTIG. El evento está programado para el martes 11 de febrero de 2025, en The Cliff Lodge en Snowbird, Utah.
Personalis (Nasdaq: PSNL)는 정밀 온콜로지 분야를 위한 고급 유전체학의 선두 기업으로, 경영진 팀이 BTIG 연례 MedTech, 디지털 헬스, 생명 과학 및 진단 도구 컨퍼런스에 참여할 예정이라고 발표했습니다. 이 행사는 2025년 2월 11일 화요일에 유타주 스노우버드의 The Cliff Lodge에서 열릴 예정입니다.
Personalis (Nasdaq: PSNL), une entreprise leader dans la génomique avancée pour l'oncologie de précision, a annoncé la prochaine participation de son équipe de direction à la Conférence Annuelle MedTech, Santé Numérique, Sciences de la Vie et Outils Diagnostiques de BTIG. L'événement est prévu pour le mardi 11 février 2025, au The Cliff Lodge à Snowbird, Utah.
Personalis (Nasdaq: PSNL), ein führendes Unternehmen in der fortschrittlichen Genomik für präzise Onkologie, hat die bevorstehende Teilnahme seines Management-Teams an der BTIG Jahreskonferenz für MedTech, digitale Gesundheit, Lebenswissenschaften und Diagnosetools bekannt gegeben. Die Veranstaltung findet am Dienstag, den 11. Februar 2025, im The Cliff Lodge in Snowbird, Utah, statt.
- None.
- None.
About Personalis, Inc.
At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest timepoints, enable selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250128738322/en/
Investors:
Caroline Corner
investors@personalis.com
415-202-5678
Media:
pr@personalis.com
Source: Personalis, Inc.
FAQ
When is Personalis (PSNL) presenting at the BTIG MedTech Conference 2025?
Where is the 2025 BTIG MedTech Conference featuring Personalis (PSNL) being held?
What type of conference is Personalis (PSNL) attending in February 2025?
What is Personalis's (PSNL) primary business focus according to the BTIG conference announcement?
